The Food and Drug Administration announced a Class II recall for more than 7,000 bottles of an antidepressant due to a chemical.
The recall was initiated earlier this month on Oct. 10.
Duloxetine, reportedly known under brands like Cymbalta, is used to treat mental health disorders like anxiety and depression, among other conditions, according to the Cleveland Clinic. The product was distributed across the country and manufactured by Towa Pharmaceutical Europe.
The agency noted the medication had the "presence" of nitrosamine drug substance impurity, N-nitroso-duloxetine.
Per the FDA, nitrosamine impurities "may increase the risk of cancer if people are exposed to them above acceptable levels and over long periods of time."